Medindia

X

Targeting T Cells Effective In Multiple Sclerosis Treatment

by Gopalan on  February 24, 2011 at 2:10 PM Research News   - G J E 4
Targeting T cells is effective in multiple sclerosis treatment, assert US researchers. The Wayne University scientists have been able to block the disease in an animal model of MS, experimental autoimmune encephalomyelitis. The study has been published in the January 2011 edition of the Journal of Neuroimmunology.
 Targeting T Cells Effective In Multiple Sclerosis Treatment
Targeting T Cells Effective In Multiple Sclerosis Treatment
Advertisement

Normally, T cells are programmed to attack foreign substances in the body. However, sometimes these T cells attack an essential component of the central nervous system, the protective layer of nerve cells known as the myelin sheath. This causes the symptoms associated with MS, which include tremors, fatigue, memory loss and other problems.

Advertisement
The debate was centered on treatment of the most common form of the disease, the remitting-relapse form, in which attack episodes alternate with periods of remission. Roughly 85 percent of the 2.5 million sufferers of MS worldwide exhibit the remitting-relapse pattern.

Scientists came up with two conflicting conjectures. Some found that the T cells involved in each relapse were different and were directed against different myelin proteins. As such, these T cells are not suitable targets for therapy. Others, however, could not find support for this in their studies. "It was important to resolve this issue because the two models suggested totally different therapeutic approaches," said Harley Tse, Ph.D., associate professor of immunology and microbiology at WSU's School of Medicine and author of the new study.

Studying the possibilities, Tse constructed a special mouse strain to tag the disease-causing T cells and observed that when these marked T cells were eliminated after a relapse, subsequent relapses did not occur.

"Elimination of marked donor T cells could be done after development of the second or the third relapse episodes and each time, no further relapses occurred," said Tse. "This work is significant because for the first time we are able to definitively establish a cause-and-effect relationship linking the marked T cells to the development of relapses and show unambiguously that it was the same T cells that mediated relapsing cycles. "

"Targeting such disease-causing T cells in MS is definitely a valid therapeutic approach that should be pursued," Tse added.

Other WSU researchers involved in the study were Jinzhu Li, M.D., Ph.D., Xiaoqing Zhao, M.D., Ph.D, Hui-Wen Hao, M.D., Ph.D. and Michael K. Shaw, Ph.D. Tse's study was supported in part by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and the National Multiple Sclerosis Society.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All